Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder: Assessing Mechanism Using Functional Neuroimaging
A Brain Imaging Study of Nabilone for Individuals with OCD
Sponsor:Youth Anxiety Center of New York Presbyterian Hospital
Enrolling:Male and Female Patients
Study Length:3 Days
Clinic Visits:3
Age Range:Between 21 and 55 years old
IRB Number:7809
Contact: Sarah Altman-Ezzard: 646-774-8062 /
Additional Study Information:

The Center for OCD Research at Columbia University Irving Medical Center is seeking individuals with obsessive-compulsive disorder (OCD) to participate in a research study, at no cost to you. This study is investigating the medicinal effects of nabilone for OCD symptoms. Nabilone is a synthetic form of tetrahydrocannabinol (THC), which is one of the active ingredients of marijuana. Participants who enroll will receive study medication or placebo, receive assessments and an MRI scan, and complete behavioral tasks.

Do You Qualify?
Are you currently suffering from obsessive-compulsive disorder (OCD)?YesNo
Are you currently taking psychiatric medications?YesNo
Do you have any metal in your body?YesNo
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Sarah Altman-Ezzard
Phone: 646-774-8062